Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookNational Drug Policy - Nigeria (FMOH, WHO; 2005; 32 pages)
View the documentFOREWORD
View the documentACKNOWLEDGEMENTS
View the documentACRONYMS
View the document1.0 INTRODUCTION
View the document2.0 DEFINITION
View the document3.0 GOALS OF THE NATIONAL DRUG POLICY
View the document4.0 OBJECTIVES OF THE NATIONAL DRUG POICY
View the document5.0. TARGETS OF THE NATIONAL DRUG POLICY
close this folder6.0 STRATEGIES FOR IMPLEMENTING THE NATIONAL DRUG POLICY
View the document6.1 SELECTION OF DRUGS
View the document6.2 PROCUREMENT OF DRUGS
View the document6.3 DRUG REVOLVING FUND SCHEME
View the document6.4 PRICING POLICY
View the document6.5 DRUG STORAGE
View the document6.6 DRUG DISTRIBUTION
Open this folder and view contents6.7 RATIONAL DRUG USE
View the document6.8 DONATED DRUGS
View the document6.9 LOCAL DRUG PRODUCTION
View the document6.10 LEGISLATION
View the document6.11 INSPECTION OF DRUGS
View the document6.12 IMPORTATION AND EXPORTATION OF DRUGS
View the document6.13 REGISTRATION OF DRUGS
View the document6.14 PATENTS
View the document6.15 QUALITY ASSURANCE
Open this folder and view contents6.16 REGULATIONS FOR PRESCRIBING AND DISPENSING DRUGS
View the document6.17 PHARMACOVIGILANCE
View the document6.18 DRUG INFORMATION AND PROMOTION
View the document6.19 DRUG FINANCING AND AFFORDABILITY
Open this folder and view contents6.20 RESEARCH AND DEVELOPMENT
View the document6.21 HERBAL AND OTHER TRADITIONAL REMEDIES
View the document6.22 HUMAN RESOURCES DEVELOPMENT
View the document6.23 CONTROL OF VETERINARY DRUGS
View the document6.24 INTERNATIONAL COOPERATION
View the document6.25 MONITORING AND EVALUATION
 

6.8 DONATED DRUGS

Experience has shown that some donated drugs have often not been relevant to the emergency situation for which they were donated or for the disease pattern, or for the level of care that was available. They may sometimes be unknown to local health professionals and patients and may not comply with locally agreed policies and standard treatment guidelines; they may even be harmful. In the light of this experience, the following measures shall be taken;

i All drug donations for use in the country shall be processed through the Federal Ministry of Health as a clearing house to ensure compliance with the guidelines for drug donations.

ii Donated drugs shall among other things be required to:

• be registered for use, both by the Drug Regulatory Authority of the donor country and in Nigeria,

• have at least twelve months remaining shelf life after arrival in the country, and

• be labelled in English to include its international non proprietary or generic name; and


iii. The Federal Ministry of Health shall put in place an adequate machinery for monitoring the distribution of donated drugs. In an emergency, the Federal Ministry of Health, in collaboration with National Emergency Management Agency (NEMA), shall immediately establish a co-ordinating body to assess and inform donors about national needs, approve donations, and co-ordinate their receipt and distribution.

to previous sectionto next section

Please provide your feedback English  |  French